Back to Journals » Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy

ISSN: 1179-1314


Editor-in-Chief: Professor Pranela Rameshwar

Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

 

Latest articles:

- 5 records -

ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer

Rangel N, Sánchez IL, Valbuena DS, Rondón-Lagos M

Breast Cancer: Targets and Therapy 2024, 16:127-139

Published Date: 15 March 2024

The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients

Ma Q, Liu YB, She T, Liu XL

Breast Cancer: Targets and Therapy 2024, 16:117-126

Published Date: 8 March 2024

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N

Breast Cancer: Targets and Therapy 2024, 16:105-116

Published Date: 6 March 2024

GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer

Zhou Y, Xue W, Meng X, Bhandari A, Zeng H, KC R, Hirachan S, Xia E

Breast Cancer: Targets and Therapy 2024, 16:71-89

Published Date: 5 March 2024


Read more articles